These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4562088)

  • 1. Hypermetabolic state following renal allotransplantation.
    Jursik JJ; De Quesada AM; Shires DL; Bradley KP
    J Am Diet Assoc; 1972 Nov; 61(5):541-4. PubMed ID: 4562088
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue immunity and organ transplantation.
    Russell PS
    Surg Gynecol Obstet; 1968 Jun; 126(6):1203-15. PubMed ID: 4172388
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation.
    Seigler HF; Gunnells JC; Robinson RR; Ward FE; Amos DB; Rowlands DT; Burkholder PM; Klein WJ; Stickel DL
    J Clin Invest; 1972 Dec; 51(12):3200-15. PubMed ID: 4565678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of peripheral blood leukocyte activity following canine renal allotransplantation.
    Pauly JL; Varkarakis MJ; Germain MJ; Murphy GP
    J Med; 1974; 5(5):221-8. PubMed ID: 4606248
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
    Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
    Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of macrocytosis during azathioprine therapy after renal transplantation. A correlation of renal function with MCV.
    Nicholls AJ; Davidson RJ
    Transplantation; 1979 Mar; 27(3):220-1. PubMed ID: 373186
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B; Korn A
    Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial.
    First MR; Schroeder TJ; Michael A; Hariharan S; Weiskittel P; Alexander JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):591-4. PubMed ID: 8438428
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term survivors following renal allotransplantation.
    Lee CJ; Lee JM; Lee CS; Lee PH; Lan C; Chou CC
    Transplant Proc; 1994 Aug; 26(4):2093-6. PubMed ID: 8066682
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
    Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
    Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
    Vanrenterghem Y; Peeters J
    Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165
    [No Abstract]   [Full Text] [Related]  

  • 12. Is a late graft biopsy at 3 years after transplantation effective for improving the long-term outcome of renal allografts using cyclosporine?
    Morozumi K; Takeda A; Uchida K; Oda A; Oikawa T; Sugito K; Kodera K; Fujinami T; Tominaga Y; Yoshida A
    Transplant Proc; 1994 Apr; 26(2):945-8. PubMed ID: 8171713
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 14. Large volume diuresis as a mechanism for immediate maximum renal function after transplantation.
    Diethelm AG; Aldrete JS; Sterling WA; Morgan JM
    Surg Gynecol Obstet; 1974 Jun; 138(6):869-74. PubMed ID: 4597109
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 16. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.
    van Wezel HB; Hilbrands LB; Koene RA; Hoitsma AJ
    Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome of live-related donor renal transplants in their second decade.
    Georgi BA; Cacciarelli TV; Sumrani N; Goldberg K; Hong JH; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2164-5. PubMed ID: 8516853
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of immunosuppressive drug therapy on blood urea nitrogen concentration in dogs with azotemia.
    Finco DR; Barsanti JA; Rawlings CA
    J Am Vet Med Assoc; 1984 Sep; 185(6):664-5. PubMed ID: 6386773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.